Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lixte Biotechnology Holdings (LIXT) Payables (2016)

Lixte Biotechnology Holdings' Payables history spans 7 years, with the latest figure at $112107.0 for Q3 2016.

  • For Q3 2016, Payables fell 7.49% year-over-year to $112107.0; the TTM value through Sep 2016 reached $112107.0, down 7.49%, while the annual FY2015 figure was $161076.0, N/A changed from the prior year.
  • Payables reached $112107.0 in Q3 2016 per LIXT's latest filing, up from $77506.0 in the prior quarter.
  • In the past five years, Payables ranged from a high of $161076.0 in Q4 2015 to a low of $64617.0 in Q3 2013.
  • Average Payables over 5 years is $94583.9, with a median of $86309.0 recorded in 2012.
  • Peak YoY movement for Payables: skyrocketed 101.94% in 2014, then fell 29.78% in 2015.
  • A 5-year view of Payables shows it stood at $80416.0 in 2012, then surged by 34.02% to $107774.0 in 2013, then grew by 21.08% to $130490.0 in 2014, then increased by 23.44% to $161076.0 in 2015, then tumbled by 30.4% to $112107.0 in 2016.
  • Per Business Quant, the three most recent readings for LIXT's Payables are $112107.0 (Q3 2016), $77506.0 (Q2 2016), and $85403.0 (Q1 2016).